Perspective: Regulatory Bill Could be Dangerous for FDA, Public Health
By Zachary Brennan -
Published 21 December 2017
A bill making its way through Congress could end up having "potentially disastrous consequences" for the US Food and Drug Administration (FDA) and public health, professors from the Program on Regulation, Therapeutics, and Law at Harvard Medical School and the Georgia State University College of Law, wrote in the New England Journal of Medicine this week.
Categories: News, US, FDA, Government affairs, Regulatory intelligence, Regulatory strategy
Tags: regulations, Regulatory Accountability Act, FDA rulemakings